Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Anderson

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Carcinogenesis|November 1, 1989
N-nitrosocimetidine as an initiator of murine skin tumors with associated H-ras oncogene activationL M Anderson, T Enomoto, A O Perantoni, et al.
Oncogene|June 22, 2010
miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancerW Liu, O Zabirnyk, H Wang, et al.
Toxicology and Applied Pharmacology|July 25, 2000
DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in fetal tissues of patas monkeys after transplacental exposureS Josyula, L J Lu, J J Salazar, et al.
Cancer Research|July 15, 1990
Interspecies scaling of the pharmacokinetics of N-nitrosodimethylamineC T Gombar, G W Harrington, H M Pylypiw, et al.
Carcinogenesis|January 14, 1999
Implications of p53 mutation spectrum for cancer etiology in gastric cancers of various histologic types from a high-risk area of central ItalyY H Shiao, D Palli, G S Buzard, et al.
Carcinogenesis|January 1, 1997
Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr miceM A Sipowicz, C M Weghorst, Y H Shiao, et al.
Reproductive Toxicology (Elmsford, N.Y.)|January 1, 1997
Transplacental cisplatin exposure induces persistent fetal mitochondrial and genomic DNA damage in patas monkeysA J Giurgiovich, L M Anderson, A B Jones, et al.
Molecular Carcinogenesis|October 10, 1998
Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidineZ Zhang, B A Diwan, L M Anderson, et al.
Carcinogenesis|July 27, 2000
A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activityD Ramljak, R J Calvert, P W Wiesenfeld, et al.
Toxicology Letters|October 20, 2001
Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-rasI M McKenna, G Ramakrishna, B A Diwan, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Carcinogenesis|November 1, 1989
N-nitrosocimetidine as an initiator of murine skin tumors with associated H-ras oncogene activationL M Anderson, T Enomoto, A O Perantoni, et al.
Oncogene|June 22, 2010
miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancerW Liu, O Zabirnyk, H Wang, et al.
Toxicology and Applied Pharmacology|July 25, 2000
DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in fetal tissues of patas monkeys after transplacental exposureS Josyula, L J Lu, J J Salazar, et al.
Cancer Research|July 15, 1990
Interspecies scaling of the pharmacokinetics of N-nitrosodimethylamineC T Gombar, G W Harrington, H M Pylypiw, et al.
Carcinogenesis|January 14, 1999
Implications of p53 mutation spectrum for cancer etiology in gastric cancers of various histologic types from a high-risk area of central ItalyY H Shiao, D Palli, G S Buzard, et al.
Carcinogenesis|January 1, 1997
Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr miceM A Sipowicz, C M Weghorst, Y H Shiao, et al.
Reproductive Toxicology (Elmsford, N.Y.)|January 1, 1997
Transplacental cisplatin exposure induces persistent fetal mitochondrial and genomic DNA damage in patas monkeysA J Giurgiovich, L M Anderson, A B Jones, et al.
Molecular Carcinogenesis|October 10, 1998
Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidineZ Zhang, B A Diwan, L M Anderson, et al.
Carcinogenesis|July 27, 2000
A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activityD Ramljak, R J Calvert, P W Wiesenfeld, et al.
Toxicology Letters|October 20, 2001
Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-rasI M McKenna, G Ramakrishna, B A Diwan, et al.
Pageof 18